NasdaqGS - Delayed Quote USD
Vaxcyte, Inc. (PCVX)
35.02
+2.53
+(7.79%)
At close: June 2 at 4:00:00 PM EDT
34.52
-0.50
(-1.43%)
After hours: June 2 at 7:33:16 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-459,777
-452,627
-296,790
-170,597
-121,393
Investing Cash Flow
-1,431,276
-2,005,666
-773,311
74,585
-212,308
Financing Cash Flow
1,631,071
2,448,508
639,813
861,547
17,796
End Cash Position
352,633
389,195
398,554
835,528
69,856
Interest Paid Supplemental Data
--
--
0
2
7
Capital Expenditure
-133,838
-119,159
-67,877
-5,841
-6,555
Issuance of Capital Stock
1,619,178
2,435,656
636,043
856,480
13,896
Repayment of Debt
--
--
--
0
0
Free Cash Flow
-593,615
-571,786
-364,667
-176,438
-127,948
12/31/2021 - 6/12/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NUVL Nuvalent, Inc.
77.18
+3.44%
IMVT Immunovant, Inc.
15.41
+3.77%
RVMD Revolution Medicines, Inc.
40.65
+3.17%
ACLX Arcellx, Inc.
61.93
-0.21%
BPMC Blueprint Medicines Corporation
127.79
+26.09%
AKRO Akero Therapeutics, Inc.
50.73
+2.18%
PTCT PTC Therapeutics, Inc.
48.83
+0.64%
APLS Apellis Pharmaceuticals, Inc.
19.14
+13.05%
ROIV Roivant Sciences Ltd.
11.17
+1.64%
CYTK Cytokinetics, Incorporated
31.21
+0.61%